Literature DB >> 15510977

How does DNA methylation mark the fate of cells?

Marcella Macaluso1, Antonio Giordano.   

Abstract

Since every cell of a multicellular organism contains the same genome, it is intriguing to understand why genetically homogenous cells are different from each other and what controls this. Several observations indicate that DNA methylation has an essential regulatory function in mammalian development, which is to establish the correct pattern of gene expression, and that DNA methylation pattern is tightly correlated with chromatin structure. Various physiological processes are controlled by specific DNA methylation patterns including genomic imprinting, inactivation of the X chromosome, regulation of tissue-specific gene expression and repression of transposons. Moreover, aberrant methylation could confer a selective advantage to cells, leading to cancerous growth. In this review we focus on the epigenetic molecular mechanisms during normal development and discuss how DNA methylation could affect the expression of genes leading to cancer transformation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15510977     DOI: 10.1177/030089160409000401

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  5 in total

1.  Many chronological aging clocks can be found throughout the epigenome: Implications for quantifying biological aging.

Authors:  Hunter L Porter; Chase A Brown; Xiavan Roopnarinesingh; Cory B Giles; Constantin Georgescu; Willard M Freeman; Jonathan D Wren
Journal:  Aging Cell       Date:  2021-10-16       Impact factor: 9.304

2.  Systematic identification of cis-silenced genes by trans complementation.

Authors:  Jae Hyun Lee; Branimir Bugarija; Enrique J Millan; Noah M Walton; Jedidiah Gaetz; Croydon J Fernandes; Wei-Hua Yu; Nitzan Mekel-Bobrov; Tammy W Vallender; Gregory E Snyder; Andy Peng Xiang; Bruce T Lahn
Journal:  Hum Mol Genet       Date:  2008-12-02       Impact factor: 6.150

3.  KSHV LANA inhibits TGF-beta signaling through epigenetic silencing of the TGF-beta type II receptor.

Authors:  Daniel L Di Bartolo; Mark Cannon; Yi-Fang Liu; Rolf Renne; Amy Chadburn; Chris Boshoff; Ethel Cesarman
Journal:  Blood       Date:  2008-01-16       Impact factor: 22.113

4.  MS-275 synergistically enhances the growth inhibitory effects of RAMBA VN/66-1 in hormone-insensitive PC-3 prostate cancer cells and tumours.

Authors:  A Khandelwal; Lk Gediya; Vco Njar
Journal:  Br J Cancer       Date:  2008-03-18       Impact factor: 7.640

5.  Chromatin analysis of occluded genes.

Authors:  Jae Hyun Lee; Jedidiah Gaetz; Branimir Bugarija; Croydon J Fernandes; Gregory E Snyder; Eliot C Bush; Bruce T Lahn
Journal:  Hum Mol Genet       Date:  2009-04-20       Impact factor: 6.150

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.